Cargando…
Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis.
Breast cancer prognosis has previously been linked to the degree of tumour vascularisation. In order to establish additional markers for tumour angiogenesis, we have used monoclonal antibodies against the endothelial Tie receptor tyrosine kinase to study the degree of vascularisation of breast carci...
Autores principales: | Salvén, P., Joensuu, H., Heikkilä, P., Matikainen, M. T., Wasenius, V. M., Alanko, A., Alitalo, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074623/ https://www.ncbi.nlm.nih.gov/pubmed/8679461 |
Ejemplares similares
-
Enhanced expression of vascular endothelial growth factor in metastatic melanoma.
por: Salven, P., et al.
Publicado: (1997) -
The TIE Receptor Family
por: Saharinen, Pipsa, et al.
Publicado: (2015) -
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.
por: Peters, K. G., et al.
Publicado: (1998) -
TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells
por: Tan, Shuran, et al.
Publicado: (2022) -
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2
por: Saharinen, Pipsa, et al.
Publicado: (2005)